GMP Tips - GSK recalls Paxil - Missing Active Ingredient - Oct 12, 2006

GlaxoSmithKline Plc recalled Paxil CR antidepressants last month because the pills may have lacked an active ingredient, and didn't warn patients. Glaxo doesn't know how many of the 7.5-million recalled pills were missing paroxetine hydrochloride, or how many patients took the pills, spokesman Michael Fleming said in a telephone interview.

Read the article detailing this at
www.gmptrainingsystems.com/asp/resources.asp
Click on Timely Resource Articles

Training Tip
Use this article in your GMP Training. Have small groups discuss how this might have occurred. Then discuss what measures that your company has in place (or needs to put in place) to prevent this from occurring.

GMP Training Systems, Inc.
www.GMPTrainingSystems.com
Serving 948 clients since 1996

David Markovitz, Founder and President of GMP Training Systems, Inc., will be conducting an audio seminar on Implementing FDA's New Guidance on a Quality Systems Approach on Thursday, October 19. For registration information, go to http://gmptrainingsystems.com/asp/bp_store_061019.asp

Please forward this post to others in your organization who might benefit.